Evaxion logo
Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.070
+0.020 (0.66%)
Oct 9, 2026, 4:00 PM EDT - Market closed

Evaxion Revenue

Evaxion had revenue of $7.49M in the twelve months ending June 30, 2026, up 135.86% year-over-year. In the year 2025, Evaxion had annual revenue of $7.53M with 125.12% growth. That makes Evaxion the 38,505th largest company in the world by revenue and 5,076th in the United States.

Revenue (ttm)
$7.49M
Revenue Growth
+135.86%
P/S Ratio
3.42
Revenue / Employee
$162,848
Employees
46
Market Cap
25.60M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.53M4.18M125.12%
Dec 31, 20243.34M3.27M4,480.82%
Dec 31, 202373.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Immutep13.79M
Kyntra Bio4.62M
Seres Therapeutics1.88M
BeyondSpring1.88M
IGC Pharma1.11M
ABVC BioPharma797.92K
aTyr Pharma190.00K
Revenue Rankings